Type 2 Diabetes

Increased mortality from cardiovascular outcomes found in overweight patients but…. 

  This week’s Homerun Slides from Dr. Stanley Schwartz cover topics including Non-insulin Therapies and the Recommended Goals for the ABC’s of Diabetes Care (A1c, BP, and Cholesterol)….

Approximately two-fold increase…. 

Effects of treatment with pravastatin, atorvastatin, and pitavastatin examined….

In this week’s Homerun Slides from Dr. Stanley Schwartz, we continue our discussion of medications, including the SGLT2 inhibitor canagliflozin and the central dopamine agonist bromocriptine. We then begin to delve into therapy for type 2 diabetes, targets for glycemic control, and targeting postprandial glucose….

  In this week’s Homerun Slides, Dr. Stanley Schwartz reviews some of the treatments patients have received in-hospital when under physical stress and compares the results of different treatment regimens….

  In this week’s series of Homerun Slides, we continue with our update on the current state of type 2 therapy with Dr. Stanley Schwartz. Topics include: Potential mechanisms of reducing CV outcomes with DPP-IV inhibitors; exenatide and CV outcomes; and Incretins in Type 2 Patients….

Metformin plus Cycloset shows significant CVD risk reduction for type 2 diabetes patients in trial….

Body fat content more significant than absolute body far amount….

Researchers review potential new drug treatment options for type 2 diabetes patients….